Benzinga | Nov 5, 2020 05:00PM EST

Emergent BioSolutions Q3 EPS $2.19 Beats $2.12 Estimate, Sales $385.20M Miss $437.93M Estimate

Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $2.19 per share which beat the analyst consensus estimate of $2.12 by 3.3 percent. This is a 80.99 percent increase over earnings of $1.21 per share from the same period last year. The company reported quarterly sales of $385.20 million which missed the analyst consensus estimate of $437.93 million by 12.04 percent. This is a 23.54 percent increase over sales of $311.80 million the same period last year.